Technology | October 07, 2013

Claron to Debut Enhanced Modality Support for Nil Universal Viewers

remote viewing system rsna 2013 claron nil universal viewer nilread

October 7, 2013 — Claron Technology will announce extended modality support for its Nil universal zero-footprint medical viewers at the Radiological Society of North America (RSNA) 2013 conference. The Nil viewer family includes NilShare, optimized for enterprise viewing, and NilRead, newly U.S. Food and Drug Administration (FDA)-cleared for diagnostic use. Also new at RSNA is support for high-definition MPEG-4 videos as well as all common image formats including JPEG, TIFF and PNG. The viewers now support full cross-enterprise document sharing (XDS), integrating healthcare enterprise (IHE) profiles, including comprehensive health level 7 (HL7) clinical document architecture (CDA) documents. The Nil viewer family is optimized for cache-less integration with remote archives, including picture archiving and communication systems (PACS) and vender neutral archives (VNA), streaming data without caching it. This allows Nil to provide the best user experience for the clinical workflow typical of universal viewers, where it is not possible to optimize data access based on a scheduled workflow.

For more information: www.clarontech.com

Related Content

MR Solutions’ dry magnet MRI system for molecular imaging on display at EMIM 2020
News | Magnetic Resonance Imaging (MRI) | February 28, 2020
February 28, 2020 — MR Solutions will be displaying its la
The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

News | Artificial Intelligence | February 13, 2020
February 13, 2020 — The U.S.
A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast

A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast. (A) Unenhanced fat-saturated T1-weighted MRI shows extreme amount of FGT (ACR d). (B) Moderate BPE is seen on dynamic contrast-enhanced MRI at 90 s. (C) Mean ADC of breast parenchyma of contralateral breast on diffusion-weighted imaging with ADC mapping is 1.5 × 10?3 mm2/s. (D) On 18F-FDG PET/CT, lesion is not 18F-FDG-avid, and BPU of normal breast parenchyma is relatively high, with SUVmax of 3.2. Photo courtesy of K Pinker, et al., Medical University of Vienna, Vienna, Austria

News | PET-MRI | January 27, 2020
January 27, 2020 — Researchers have identified several potentially useful...
Nuclear imaging of the spine shown on Philips Healthcare BrightView XCT

Image courtesy of Philips Healthcare

News | Nuclear Imaging | January 27, 2020
January 27, 2020 — According to the new market research report "...
Videos | RSNA | January 13, 2020
ITN Editor Dave Fornell takes a tour of some of the most innovative new medical imaging technologies displayed on the
News | Remote Viewing Systems | December 27, 2019
December 27, 2019 — The Radiological Society of North America (RSNA) and Carequality have developed the Imaging Data
Feinstein Institutes' Thomas Chaly, Ph.D., poses in front of a PET-CT imaging machine. He has been instrumental in pushing for FDA approval of a new PET imaging agent, Fluorodopa F-18 (FDOPA), to combat Parkinson’s

Feinstein Institutes' Thomas Chaly, Ph.D., in front of a PET-CT imaging machine. He has been instrumental in pushing for FDA approval of a new PET imaging agent, Fluorodopa F-18 (FDOPA), to combat Parkinson’s

News | Nuclear Imaging | December 26, 2019
December 26, 2019 — The Feinstein Institutes for Medical R...